Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Neurosteroids show promise for treating epilepsy and more research is needed.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

The study found that family history, personal history of adolescent acne, no pregnancies, hirsutism, office work, stress, and low intake of fruits/vegetables and fish are risk factors for adult female acne.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

AGA more common in men, increases with age, linked to family history, hypertension, dyslipidemia, and smoking.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Finasteride causes lasting fertility decrease in rats.